ABSTRACT
INTRODUCTION
common form of pharmacologic treatment therapy mechanistic side effects related to effect of these evoked bladder contraction and alternative approach may be to develop drugs acting on the storage phase the muscarinic receptor antagonists act during the that bladder relaxation mediated by -adrenoceptors will be a viable target, because increased relaxation of the detrusor smooth muscle will lengthen the duration of storage phase in micturition cycle and thereby evoked by -adrenoceptor agonists is mainly mediated by 3-adrenoceptor agonist are said to stimulate the G protein -nophosphate and causes relaxation of smooth muscle -adrenoreceptor induced relaxation of bladder are -der are represented by 3-adrenoceptor agonists have been shown as compared with 1 and 2-adrenoceptor agonists, , and this was observed in normal and neurogenic bladthis was observed in normal and neurogenic blad-3-adrenoceptor agonists are expected to be -adrenoceptors in human bladder has been previously reported using receptor-binding studies, but the anatomical of -adrenoceptor are expressed in the urothelium has are expressed in the urothelium has Expression of of -adrenoceptors in urothelium is favored by the mounting evidence in support of a important role played by bladder epithelial cells in modulating bladder activity in response to local chemical and mechanical stimuli n this study, we aimed to investigate the we aimed to investigate the to investigate the presence of 1-, 2-and 3-adrenoceptor in separate tissue of urothelium and detrusor muscle from human 3-adrenoceptors , a selective a selective 3-adrenoceptor agonist
MATERIALS AND METHODS
Human bladders -The human bladders were informed consent from the next of kin of the six organ donors using an honest broker system from the Health disease status of organ donors was not available to -ventitia was removed and longitudinal detrusor strips sutures were tied to each end of the strips, and tissues 
COMMENTS
has deterdeter--renoceptor in the human bladder, but the anatomical the human bladder, but the anatomical human bladder, but the anatomical bladder, but the anatomical anatomical distribution of expression in bladder in terms of of expression in bladder in terms of urothelium and detrusor has not been determined The -adrenoceptors expressed agonists on micturition is mediated principally by Our results on the -der generally agree with the earlier study showing relaxation of human detrusor strip pre-contracted few notable EFS (5, 10, 15 Hz) in the presence of oxygenated Krebs' solution, 
M). Both the drugs suppressed EFS evoked detrusor contraction at 10 -4 M concentration. The maximum suppression was observed at EFS induced contractions of lower frequencies as 5 Hz.
in intracellular Ca 2+ following activation of the induced by a chemical irritant, cyclophosphamide in ; it is believed better explained by suppression of excitability of and/or the release of transmitters from bladder afferent information about -adrenoceptors expressed in the human urothelium might be involved in the regulation 2--and 3-adrenergic receptors existing in the human detrusor can produce direct relaxation of the detrusor smooth muscle without blocking voiding induced -adrenergic-stimulated relaxation is mediated through the stimulation 3-adrenoceptor activation in mediating the relaxation of human detrusor by 3-adrenoceptor agonists was demonstrated by lack adrenoceptor agonists was demonstrated by lack agonists was demonstrated by lack of suppression of its effect by selective 1 and/or and/or 2-adrenoceptor antagonists such as dobutamine and -adrenoceptor antagonists such as dobutamine and 3-adrenoceptor is further -ation by selective Considering the role of 3-adrenoceptors in modulating the control of bladder smooth muscle tone in humans; these results support the hypothesis that a useful clinical strategy for -adrenoceptor adrenoceptor antagonists blockers have also been advocated for stress urinary incontinence owing to inappropriate -vents the reduction in urethral pressure after sacral -adrenoceptor anadrenoceptor an-antagonists are not particularly useful in treating bladder or direct acting smooth muscle relaxants, can produce the result of urinary retention and other mechanistic
CONCLUSIONS
The present study demonstrates that stimulation of bladder relaxation, suggesting that selective 3-adrenoceptor agonist may be a valuable new treatment for 1-, 2-and 3-adrenoceptors in urothelium apart from detrusor may suggest additional mechanism of action for the
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